- Q1 2024 Merck KGaA Earnings Call TranscriptMay 15, 2024€165.78 (+4.47%)Earnings
- Q4 2023 Merck KGaA Earnings Press Conference TranscriptMar 07, 2024
- Merck KGaA at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Q3 2023 Merck KGaA Earnings Call TranscriptNov 09, 2023€153.83 (+3.52%)Earnings
- Merck KGaA Capital Markets Day TranscriptOct 19, 2023
- Q2 2023 Merck KGaA Earnings Call TranscriptAug 03, 2023€163.78 (+3.26%)Earnings
- Q2 2023 Merck KGaA Earnings Press Conference TranscriptAug 03, 2023
- Q1 2023 Merck KGaA Earnings Call TranscriptMay 11, 2023€165.65 (+2.79%)Earnings
- Merck KGaA Annual Shareholders Meeting TranscriptApr 28, 2023
- Q4 2022 Merck KGaA Earnings Call TranscriptMar 02, 2023€179.83 (+1.64%)Earnings
- Merck KGaA at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Merck KGaA R&D Update Call TranscriptNov 21, 2022
- Q3 2022 Merck KGaA Earnings Call TranscriptNov 10, 2022€177.43 (+3.83%)Earnings
- Merck KGaA Capital Markets Day TranscriptOct 06, 2022
- Q2 2022 Merck KGaA Earnings Call TranscriptAug 04, 2022€184.88 (+0.56%)Earnings
- Q1 2022 Merck KGaA Earnings Call TranscriptMay 12, 2022€160.73 (-5.15%)Earnings
- Merck KGaA Annual Shareholders Meeting TranscriptApr 22, 2022
- Full Year 2021 Merck KGaA Earnings Call TranscriptMar 03, 2022€176.35 (+0.99%)Earnings
- Merck KGaA at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Merck KGaA R&D Update Call TranscriptNov 22, 2021
- Q3 2021 Merck KGaA Earnings Call TranscriptNov 11, 2021€205.5 (-0.36%)Earnings
- Merck KGaA Capital Markets Day (Virtual) TranscriptSep 09, 2021
- Half Year 2021 Merck KGaA Earnings Call TranscriptAug 05, 2021€188.03 (+6.56%)Earnings
- Q1 2021 Merck KGaA Earnings Call TranscriptMay 12, 2021€135.53 (-1.81%)Earnings
- Merck KGaA Annual Shareholders Meeting TranscriptApr 23, 2021
- Full Year 2020 Merck KGaA Earnings Call TranscriptMar 04, 2021€133.2 (+0.68%)Earnings
- Merck KGaA Bintrafusp alfa 037 Ad-Hoc - Capital Markets Q&A Call TranscriptJan 20, 2021
- Merck KGaA at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Merck KGaA at PR Newswire and BetterInvesting (NAIC) Deutsche Bank Depositary Receipts Virtual Investor Conference TranscriptNov 19, 2020
- Q3 2020 Merck KGaA Earnings Call TranscriptNov 12, 2020€130.7 (-0.63%)Earnings
- Merck KGaA CMD - Healthcare:R&D Update Call TranscriptSep 25, 2020
- Merck KGaA Capital Markets Day (virtual) - Performance Materials: Semiconductor Solutions TranscriptSep 16, 2020
- Merck KGaA Capital Markets Day (virtual) - Life Science: Process Solutions TranscriptSep 16, 2020
- Merck KGaA Capital Markets Day (virtual) - CEO/CFO Session and Board Q&A TranscriptSep 16, 2020
- Half Year 2020 Merck KGaA Earnings Call TranscriptAug 06, 2020€113.08 (+1.44%)Earnings
- Merck KGaA Annual Shareholders Meeting TranscriptMay 28, 2020
- Q1 2020 Merck KGaA Earnings Call TranscriptMay 14, 2020€103.25 (-3.14%)Earnings
- Merck KGaA at PR Newswire and BetterInvesting (NAIC) Deutsche Bank Depositary Receipts Virtual Investor Conference TranscriptMar 18, 2020
- Full Year 2019 Merck KGaA Earnings Call TranscriptMar 05, 2020€115.35 (+1.27%)Earnings
- Merck KGaA Evobrutinib (RMS) Update Call TranscriptFeb 20, 2020
- Merck KGaA at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Q3 2019 Merck KGaA Earnings Call TranscriptNov 14, 2019€106.03 (-3.39%)Earnings
- Merck KGaA Capital Market Day TranscriptSep 11, 2019
- Half Year 2019 Merck KGaA Earnings Call TranscriptAug 08, 2019€94.38 (+1.66%)Earnings
- Merck KGaA R&D Update Call TranscriptJun 14, 2019
- Oncolytics Biotech Inc. - Shareholder/Analyst Call TranscriptJun 05, 2019
- Q1 2019 Merck KGaA Earnings Call TranscriptMay 14, 2019€92.09 (-3.55%)Earnings
- Merck KGaA Annual Shareholders Meeting TranscriptApr 26, 2019
- Merck KGaA Signs Definitive Agreement to Acquire Versum Materials Call TranscriptApr 12, 2019
- Merck KGaA FDA Approval of MAVENCLAD Conference Call TranscriptApr 01, 2019
- Full Year 2018 Merck KGaA Earnings Call TranscriptMar 07, 2019€93.23 (-0.03%)Earnings
Merck KGaA R&D Update Call Transcript
Dear ladies and gentlemen, welcome to the Merck R&D Update Call. (Operator Instructions) May I now hand you over to Constantin Fest, Head of Investor Relations, who will lead you through this conference. Please go ahead, sir.
Thank you, Alan. Dear ladies and gentlemen, a very warm welcome to this 2021 Merck R&D Update Call. My name is Constantin Fest, and I'm Head of Investor Relations here at Merck. I'm delighted also to have with me here today, Danny Bar-Zohar, Head of Development; Joern-Peter Halle, Head of Research; as well as Andrew Paterson, Chief Marketing Officer.
For the Q&A part of this call, we will also be joined by Andree Blaukat, Head of Research Oncology, Amy Kao, Head of Research Immunology; Jan Klatt, Head of Development Neurology & Immunology; as well as Victoria Zazulina, Head of Development Oncology.
We will now guide you through the key slides of this presentation. This will be then followed by a Q&A for you to ask all your questions.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)